About Progenbiolab Technologies
Progenbiolab Technologies is a company based in Delhi (India) founded in 2018. It operates as a B2B and D2C. Progenbiolab Technologies offers products and services including ELISA Kits, Testing Services, Training Services, Next-Generation Sequencing, and Primer Synthesis. Progenbiolab Technologies operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
- Headquarter Delhi, India
-
Sectors
AgricultureHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Progenbiolab Technologies Private Limited
- Date of Incorporation 03 Dec, 2019
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$279.66 K (USD)148.59as on Mar 31, 2022
-
Net Profit
$415.03 (USD)-75.64as on Mar 31, 2022
-
EBITDA
$19.05 K (USD)1190.01as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Progenbiolab Technologies
Progenbiolab Technologies offers a comprehensive portfolio of products and services, including ELISA Kits, Testing Services, Training Services, Next-Generation Sequencing, and Primer Synthesis.
Kits for accurate protein detection in research and diagnostics.
Comprehensive testing for pharmaceuticals and biotechnology applications.
Programs on food analysis and microbial techniques for professionals.
Advanced genomic solutions for research and therapeutic needs.
Custom oligonucleotides for research and diagnostic purposes.
Funding Insights of Progenbiolab Technologies
Detailed funding history for Progenbiolab Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Progenbiolab Technologies
Investment portfolio details for Progenbiolab Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Progenbiolab Technologies
Detailed financials for Progenbiolab Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Progenbiolab Technologies Comparisons
Peer comparison for Progenbiolab Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Progenbiolab Technologies
Progenbiolab Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of Progenbiolab Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Progenbiolab Technologies
Complete news archive for Progenbiolab Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Progenbiolab Technologies
Progenbiolab Technologies was founded in 2018.
Progenbiolab Technologies is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Annual revenue of Progenbiolab Technologies is $279.66K as on Mar 31, 2022.
Progenbiolab Technologies Specializes In Providing Research, Analytical, And Training Services In Biotechnology And Food Testing. They Offer Products Like Elisa Kits, Testing Services For Pharmaceuticals And Food, And Training Programs On Microbial And Pesticide Analysis. Based In New Delhi, India, They Serve Food Manufacturers, Professionals, And Academics Through Custom Solutions Like Gene Synthesis And Diagnostic Services, Ensuring Quality And Safety Standards.
Progenbiolab Technologies's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Progenbiolab Technologies offers ELISA Kits, Testing Services, Training Services, Next-Generation Sequencing, and Primer Synthesis.